Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
life sciences & biomedicine (38) 38
science & technology (38) 38
hematology (32) 32
humans (32) 32
transplantation (28) 28
middle aged (26) 26
male (25) 25
adult (23) 23
female (23) 23
aged (20) 20
hematology, oncology and palliative medicine (19) 19
hematopoietic stem cells (12) 12
stem cells (12) 12
abridged index medicus (10) 10
chronic disease (10) 10
immunology (10) 10
young adult (10) 10
medical research (9) 9
medicine, experimental (9) 9
graft vs host disease - drug therapy (8) 8
leukemia (8) 8
oncology (8) 8
adolescent (7) 7
hematopoietic stem cell transplantation (7) 7
prospective studies (7) 7
treatment outcome (7) 7
clinical trials (6) 6
graft vs host disease - etiology (6) 6
hematopoietic stem cell transplantation - adverse effects (6) 6
research (6) 6
survival rate (6) 6
transplantation, homologous (6) 6
child (5) 5
chronic graft-versus-host disease (5) 5
graft vs host disease - diagnosis (5) 5
graft vs host disease - mortality (5) 5
graft vs host disease - pathology (5) 5
risk factors (5) 5
acute disease (4) 4
acute myeloid leukemia (4) 4
analysis (4) 4
antimitotic agents (4) 4
antineoplastic agents (4) 4
azacitidine - analogs & derivatives (4) 4
bone marrow (4) 4
bronchiolitis obliterans syndrome (4) 4
decitabine (4) 4
disease-free survival (4) 4
general & internal medicine (4) 4
graft vs host disease - blood (4) 4
hematopoietic cell transplantation (4) 4
hematopoietic stem cell transplantation - methods (4) 4
hemic and lymphatic diseases (4) 4
leukemia, myeloid, acute - drug therapy (4) 4
leukemia, myeloid, acute - therapy (4) 4
medical colleges (4) 4
medicine, general & internal (4) 4
mortality (4) 4
myelodysplastic syndrome (4) 4
pyrazoles - therapeutic use (4) 4
severity of illness index (4) 4
stem cell transplantation (4) 4
steroids (4) 4
surgical procedures, operative (4) 4
survival analysis (4) 4
aged, 80 and over (3) 3
allogeneic hematopoietic cell transplantation (3) 3
allografts (3) 3
antimetabolites, antineoplastic - adverse effects (3) 3
azacitidine - administration & dosage (3) 3
azacitidine - adverse effects (3) 3
bone marrow transplantation (3) 3
bronchiolitis obliterans - etiology (3) 3
care and treatment (3) 3
chemotherapy (3) 3
disease progression (3) 3
drug administration schedule (3) 3
fluticasone (3) 3
graft vs host disease - prevention & control (3) 3
health aspects (3) 3
hematologic neoplasms - therapy (3) 3
leukemia, myeloid, acute - genetics (3) 3
montelukast (3) 3
multivariate analysis (3) 3
mutation (3) 3
myelodysplastic syndromes - drug therapy (3) 3
myelodysplastic syndromes - genetics (3) 3
myelodysplastic syndromes - therapy (3) 3
patients (3) 3
prognosis (3) 3
pyrazoles - pharmacology (3) 3
recurrence (3) 3
retrospective studies (3) 3
risk assessment (3) 3
time factors (3) 3
united states (3) 3
5-aza-2'-deoxycytidine (2) 2
acetates - therapeutic use (2) 2
albumin (2) 2
anti-inflammatory agents - therapeutic use (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Association of Leukemia Cutis With Survival in Acute Myeloid Leukemia
by Wang, Cynthia X and Pusic, Iskra and Anadkat, Milan J
JAMA dermatology (Chicago, Ill.), ISSN 2168-6068, 07/2019, Volume 155, Issue 7, pp. 826 - 832
Life Sciences & Biomedicine | Dermatology | Science & Technology
Journal Article
Details down arrow
2. Full Text Ruxolitinib: A steroid sparing agent in chronic graft-versus-host disease
by Khoury, Hanna Jean and Langston, Amelia A and Kota, Vamsi K and Wilkinson, Jennifer A and Pusic, Iskra and Jillella, Anand and Bauer, Stephanie and Kim, Audrey S and Roberts, Danielle and Al-Kadhimi, Zaid and Bodo, Imre and Winton, Elliott and Arellano, Martha and Dipersio, John F
Bone marrow transplantation (Basingstoke), ISSN 0268-3369, 07/2018, Volume 53, Issue 7, pp. 826 - 831
Immunology | Life Sciences & Biomedicine | Hematology | Oncology | Transplantation | Biophysics | Science & Technology | Pyrazoles - therapeutic use | Janus Kinases - therapeutic use | Humans | Janus Kinases - pharmacology | Middle Aged | Male | Graft vs Host Disease - pathology | Graft vs Host Disease - drug therapy | Adult | Female | Aged | Chronic Disease | Pyrazoles - pharmacology | Systemic scleroderma | Scleroderma (Disease) | Research | Graft-versus-host reaction | Salvage | Intestine | Vagina | Scleroderma | Kinases | Steroid hormones | Steroids | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Challenges in Conducting Studies in Chronic Graft-versus-Host Disease
by Iskra Pusic and Steven Z. Pavletic
Clinical hematology international, 03/2019, Volume 1, Issue 1
GvHD | GRFS | FFS | Composite endpoints | Response criteria
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Ibrutinib for chronic graft-versus-host disease after failure of prior therapy
by Miklos, David and Cutler, Corey S and Arora, Mukta and Waller, Edmund K and Jagasia, Madan and Pusic, Iskra and Flowers, Mary E and Logan, Aaron C and Nakamura, Ryotaro and Blazar, Bruce R and Li, Yunfeng and Chang, Stephen and Lal, Indu and Dubovsky, Jason and James, Danelle F and Styles, Lori and Jaglowski, Samantha
Blood, ISSN 0006-4971, 11/2017, Volume 130, Issue 21, pp. 2243 - 2250
Life Sciences & Biomedicine | Hematology | Science & Technology | Pyrazoles - therapeutic use | Demography | Protein-Tyrosine Kinases - metabolism | Humans | Middle Aged | Male | Adrenal Cortex Hormones - therapeutic use | Dose-Response Relationship, Drug | Young Adult | Treatment Failure | Adult | Female | Pyrazoles - adverse effects | Pyrazoles - pharmacology | Biomarkers - metabolism | Severity of Illness Index | Graft vs Host Disease - blood | Pyrimidines - pharmacology | Protein-Tyrosine Kinases - blood | Graft vs Host Disease - drug therapy | Pyrimidines - therapeutic use | Agammaglobulinaemia Tyrosine Kinase | Pyrimidines - adverse effects | Aged | Chronic Disease | Protein-Tyrosine Kinases - antagonists & inhibitors | Index Medicus | Abridged Index Medicus | Plenary Paper
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text The use of ruxolitinib for acute graft‐versus‐host disease developing after solid organ transplantation
by Jacobs, Miriam T and Olson, Marissa and Ferreira, Bruna Pellini and Jin, Ramon and Hachem, Ramsey and Byers, Derek and Witt, Chad and Ghobadi, Armin and DiPersio, John F and Pusic, Iskra
American journal of transplantation, ISSN 1600-6135, 02/2020, Volume 20, Issue 2, pp. 589 - 592
graft‐versus‐host disease (GVHD) | hematology/oncology | immunosuppression/immune modulation | organ transplantation in general | clinical research/practice | immunosuppressant ‐ other | Transplantation | Life Sciences & Biomedicine | Surgery | Science & Technology | Pyrazoles - therapeutic use | Graft vs Host Disease - drug therapy | Graft vs Host Disease - mortality | Humans | Middle Aged | Organ Transplantation - adverse effects | Male | Aged | Graft vs Host Disease - etiology | Postoperative Complications | Graft-versus-host reaction | Immunosuppression | Liver diseases | Allografts | Aplasia | Syngeneic grafts | Xenotransplantation | Bone marrow transplantation | Diarrhea | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Mutation Clearance after Transplantation for Myelodysplastic Syndrome
by Duncavage, Eric J and Jacoby, Meagan A and Chang, Gue Su and Miller, Christopher A and Edwin, Natasha and Shao, Jin and Elliott, Kevin and Robinson, Joshua and Abel, Haley and Fulton, Robert S and Fronick, Catrina C and O’Laughlin, Michelle and Heath, Sharon E and Brendel, Kimberly and Saba, Raya and Wartman, Lukas D and Christopher, Matthew J and Pusic, Iskra and Welch, John S and Uy, Geoffrey L and Link, Daniel C and DiPersio, John F and Westervelt, Peter and Ley, Timothy J and Trinkaus, Kathryn and Graubert, Timothy A and Walter, Matthew J
The New England journal of medicine, ISSN 0028-4793, 09/2018, Volume 379, Issue 11, pp. 1028 - 1041
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Humans | Middle Aged | Hematopoietic Stem Cell Transplantation | Bone Marrow Examination | Disease Progression | Transplantation, Homologous | Disease-Free Survival | Myelodysplastic Syndromes - therapy | DNA Mutational Analysis | Myelodysplastic Syndromes - mortality | Survival Analysis | Adult | Myelodysplastic Syndromes - genetics | Mutation | Transplantation Conditioning | Skin - pathology | Leukemia, Myeloid, Acute - genetics | Usage | Gene mutations | Development and progression | Bone-grafting | Genetic aspects | Research | Myelodysplastic syndromes | Risk factors | Flow cytometry | Syngeneic grafts | Leukemia | Genomics | Genes | Bone marrow transplantation | Stem cell transplantation | Multivariate analysis | Patients | Lymphoma | Cancer therapies | Myelodysplastic syndrome | Hemopoiesis | Studies | Gene frequency | Risk assessment | Alleles | Bone marrow | Skin | Genotypes | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Ruxolitinib for steroid‐refractory acute graft‐versus‐host disease
by Toama, Wael and Fiala, Mark and Pusic, Iskra and Westervelt, Peter and Dipersio, John F and Schroeder, Mark
Transplant international, ISSN 0934-0874, 02/2020, Volume 33, Issue 2, pp. 244 - 246
Transplantation | Life Sciences & Biomedicine | Surgery | Science & Technology | Steroids | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Engraftment of rare, pathogenic donor hematopoietic mutations in unrelated hematopoietic stem cell transplantation
by Wong, Wing Hing and Bhatt, Sima and Trinkaus, Kathryn and Pusic, Iskra and Elliott, Kevin and Mahajan, Nitin and Wan, Fei and Switzer, Galen E and Confer, Dennis L and DiPersio, John and Pulsipher, Michael A and Shah, Nirali N and Sees, Jennifer and Bystry, Amelia and Blundell, Jamie R and Shaw, Bronwen E and Druley, Todd E
Science translational medicine, ISSN 1946-6234, 01/2020, Volume 12, Issue 526, p. eaax6249
Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Cell Biology | Research & Experimental Medicine | Pilot Projects | Humans | Middle Aged | Adult | Female | Male | Hematopoietic Stem Cell Transplantation - methods | Mutation, Missense | Mutation - genetics | Graft vs Host Disease | Chemotherapy | Immunosuppression | Next-generation sequencing | Young adults | Gene frequency | Stem cell transplantation | Radiation therapy | Mutation | Hematopoietic stem cells | Age | Morbidity | Hemopoiesis | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes
by Welch, John S and Petti, Allegra A and Miller, Christopher A and Fronick, Catrina C and O’Laughlin, Michelle and Fulton, Robert S and Wilson, Richard K and Baty, Jack D and Duncavage, Eric J and Tandon, Bevan and Lee, Yi-Shan and Wartman, Lukas D and Uy, Geoffrey L and Ghobadi, Armin and Tomasson, Michael H and Pusic, Iskra and Romee, Rizwan and Fehniger, Todd A and Stockerl-Goldstein, Keith E and Vij, Ravi and Oh, Stephen T and Abboud, Camille N and Cashen, Amanda F and Schroeder, Mark A and Jacoby, Meagan A and Heath, Sharon E and Luber, Kierstin and Janke, Megan R and Hantel, Andrew and Khan, Niloufer and Sukhanova, Madina J and Knoebel, Randall W and Stock, Wendy and Graubert, Timothy A and Walter, Matthew J and Westervelt, Peter and Link, Daniel C and DiPersio, John F and Ley, Timothy J
The New England journal of medicine, ISSN 0028-4793, 11/2016, Volume 375, Issue 21, pp. 2023 - 2036
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Azacitidine - adverse effects | Prospective Studies | Humans | Middle Aged | Decitabine | Male | Tumor Suppressor Protein p53 - genetics | Antimetabolites, Antineoplastic - administration & dosage | Exome | Bone Marrow - chemistry | Aged, 80 and over | Leukemia, Myeloid, Acute - drug therapy | Adult | Female | Myelodysplastic Syndromes - drug therapy | Azacitidine - administration & dosage | 5-Methylcytosine - analysis | Biomarkers, Tumor - analysis | Risk Factors | Azacitidine - analogs & derivatives | Survival Rate | Leukemia, Myeloid, Acute - mortality | Bone Marrow - pathology | Antimetabolites, Antineoplastic - adverse effects | Myelodysplastic Syndromes - mortality | Aged | Myelodysplastic Syndromes - genetics | Mutation | Leukemia, Myeloid, Acute - genetics | Care and treatment | Research | Tumor proteins | Myelodysplastic syndromes | Myeloid leukemia | p53 Protein | Leukemia | Survival | Myelodysplastic syndrome | Risk factors | Clinical outcomes | Chemotherapy | Bone marrow | Biomarkers | Blood diseases | Acute myeloid leukemia | 5-aza-2'-deoxycytidine | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Investigating the Effects of Clonal Hematopoiesis in Healthy Marrow and Blood Donors on the Outcomes of Recipients Following Hematopoietic Stem Cell Transplantation
by Wong, Wing Hing and Elliot, Kevin and Pusic, Iskra and DiPersio, John F and Druley, Todd E
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 2180 - 2180
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Cardio‐oncology care in the era of the coronavirus disease 2019 (COVID‐19) pandemic: An International Cardio‐Oncology Society (ICOS) statement
by Lenihan, Daniel and Carver, Joseph and Porter, Charles and Liu, Jennifer E and Dent, Susan and Thavendiranathan, Paaladinesh and Mitchell, Joshua D and Nohria, Anju and Fradley, Michael G and Pusic, Iskra and Stockerl‐Goldstein, Keith and Blaes, Anne and Lyon, Alexander R and Ganatra, Sarju and López‐Fernández, Teresa and O'Quinn, Rupal and Minotti, Giorgio and Szmit, Sebastian and Cardinale, Daniela and Alvarez‐Cardona, Jose and Curigliano, Giuseppe and Neilan, Tomas G and Herrmann, Joerg
CA: a cancer journal for clinicians, ISSN 0007-9235, 11/2020, Volume 70, Issue 6, pp. 480 - 504
cardio‐oncology | cancer | coronavirus disease 2019 (COVID‐19) | pandemic | recommendations | virus | best practice | cardiac safety | coronavirus disease 2019 (COVID-19) | cardio-oncology | Life Sciences & Biomedicine | Oncology | Science & Technology | Anthracyclines - adverse effects | Cardiovascular Diseases - etiology | Cross Infection - prevention & control | Humans | Cardiovascular Diseases - therapy | COVID-19 - transmission | Trastuzumab - adverse effects | Radiotherapy - adverse effects | COVID-19 - physiopathology | Protein Kinase Inhibitors - adverse effects | Proteasome Inhibitors - adverse effects | COVID-19 - prevention & control | Neoplasms - complications | Neoplasms - therapy | SARS-CoV-2 | Antineoplastic Agents - adverse effects | COVID-19 - complications | Cardiovascular Diseases - diagnostic imaging | Receptor, ErbB-2 - antagonists & inhibitors | Referral and Consultation | Severe acute respiratory syndrome coronavirus 2 | COVID-19 | Epidemics | Pandemics | Coronaviruses | Cardiovascular diseases | Patients | Risk factors | Cancer | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Measuring Therapeutic Response in Chronic Graft-versus-Host Disease. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2014 Response Criteria Working Group Report
by Lee, Stephanie J and Wolff, Daniel and Kitko, Carrie and Koreth, John and Inamoto, Yoshihiro and Jagasia, Madan and Pidala, Joseph and Olivieri, Attilio and Martin, Paul J and Przepiorka, Donna and Pusic, Iskra and Dignan, Fiona and Mitchell, Sandra A and Lawitschka, Anita and Jacobsohn, David and Hall, Anne M and Flowers, Mary E.D and Schultz, Kirk R and Vogelsang, Georgia and Pavletic, Steven
Biology of blood and marrow transplantation, ISSN 1083-8791, 2015, Volume 21, Issue 6, pp. 984 - 999
Hematology, Oncology and Palliative Medicine | Chronic graft-versus-host disease | Allogeneic hematopoietic cell transplantation | Consensus | Response criteria | Guidelines | Transplantation | Immunology | Life Sciences & Biomedicine | Hematology | Science & Technology | United States | Hematologic Neoplasms - mortality | Humans | Immunosuppressive Agents - therapeutic use | Antineoplastic Agents - therapeutic use | Hematologic Neoplasms - pathology | Graft vs Host Disease - immunology | Transplantation, Homologous | National Institutes of Health (U.S.) | Graft vs Host Disease - mortality | Adult | Child | Biomarkers - analysis | Hematopoietic Stem Cell Transplantation | Terminology as Topic | Treatment Outcome | Clinical Trials as Topic | Remission Induction | Disease Progression | Graft vs Host Disease - pathology | Graft vs Host Disease - drug therapy | Survival Analysis | Hematologic Neoplasms - drug therapy | Hematologic Neoplasms - immunology | Chronic Disease | Measurement | Clinical trials | Political corruption | Health aspects | Index Medicus | consensus | guidelines | response criteria | allogeneic hematopoietic cell transplantation
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights